chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dehydration; Orthostatic positive with liquid watery stool/continues with liquid stool; Frequent diarrhea defined as hourly stool; A spontaneous report was received from a nurse practitioner concerning a 48-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dehydration, frequent diarrhea defined as hourly stool, orthostatic positive with liquid watery stool/continues with liquid stool.  The patient had a history of colon cancer with a colon resection. No relevant concomitant medications were reported.  On 04 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot: not provided) for prophylaxis of COVID-19 infection.  On 06 Feb 2021, the patient had frequent diarrhea defined as hourly stool. On 09 Feb 2021, she was hospitalized for 48 hours due to dehydration. She was doing fine. On 13 Feb 2021, despite the medications she was back to orthostatic positive with liquid watery stool. On 08 Mar 2021, patient continued with liquid stool. Treatment included cholestyramine, fiber, loperamide hydrochloride.  The seriousness criterion for the event dehydration was hospitalization.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the event of dehydration was resolved on an unknown date in Feb 2021. The outcome of the event, frequent diarrhea defined as hourly stool was considered as resolved. The outcome of the event, orthostatic positive with liquid watery stool/continues with liquid stool was not resolved.  The reporter did not provide an assessment for the events dehydration, frequent diarrhea defined as hourly stool, orthostatic positive with liquid watery stool/continues with liquid stool.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
COVID-19; Feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling bad). At the time of the report, COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    The patient had body aches, headaches, tired, feeling bad, no smell which are included as the COVID-19 symptoms.  Concomitant medication information was not reported  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Updated reporter's address
Initial report was received from a health care professional through another manufacturer on 09 July 2012 (Service Request Number 1-5286072150). A female patient (age not reported) had received a tetanus vaccine (manufacturer, lot number, date, site and route of administration not reported) and an unspecified amount of time later had an anaphylactic reaction. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: None.
Information has been received from a female physician with no pertinent medical history or drug reactions or allergies and was not pregnant concerning herself. It was reported that on approximately 17-MAR-2009 ZOSTAVAX (Merck) splashed in her eye while she was reconstituting the vaccine. There was no concomitant medication. The physician felt that it was likely diluent that went in her eye, but she was injecting the diluent into the ZOSTAVAX (Merck) vial when this occurred. On 17-MAR-2009 the patient was experiencing "burning" in her eye. On 18-MAR-2009 a follow-up call was made to the physician an she reported that her eye still stung, but it was a mild stinging and could be tolerated and it was constant. Otherwise, there were no other symptoms. At the time of this report, the patient was not recovered. No lab tests were done. She did not seek medical attention. Additional information has been requested.
pt recvd vax;exp intense itching over abdo,red rash;exp 2 episodes of wheezing; tx w/ meds;2mar94 pt completely recovered;
I had excellent hearing and after vaccine I have loss of hearing in both ears due to nerve damage there is no family history of hearing loss
COVID 19 Treatment; COVID 19 Treatment; fatigue; lingering cough; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 22Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 02Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 37 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Postpartum depression" (unspecified if ongoing), notes: Postpartum depression (I'm 9 months postpartum); "asthma" (unspecified if ongoing), notes: I also had asthma for a, couple of years when I was a kid.; "Allergy" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE, start date: 27Feb2022; IBUPROFEN, start date: 12Jun2022, stop date: 17Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment"; FATIGUE (non-serious), outcome "unknown"; COUGH (non-serious), outcome "unknown", described as "lingering cough". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19, fatigue, cough.  Clinical course: Woke up this morning with general malaise, fatigue, sore throat, runny nose, sneezing. These are all new symptoms except for fatigue after feeling better/recovering from initial COVID infection. I also have a lingering cough from my initial COVID infection. As day progressed, general malaise and fatigue worsened. Congestion presented in afternoon and got worse. Took one dose of OTC Zyrtec in the morning thinking it was allergies. Took one dose of Day Quil in the afternoon when still wasn't feeling well. Took my temperature this evening and it read 99.5. Decided to take an antigen test and it came back positive. No known allergies reported.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt reported to observation Desk c/o panic attack.  Restless, legs giving out, attempting to walk but unable to.  Arms and legs moving attempting to walk.  Ended up kneeling on the floor with the Cardiac surgeon holding her up.. Pt because nausead and had dry heave. skin cold/clamy Rapid resonse called. Pt then had to lay down.. B/P 86/42, 92/62, legs evevated,  O2 15 L via mask. 02 sats. 100%. Dr. ordered Epi, Pt refused.  Pt's condition improved.  RR arrived, B/P 108/72. Assisted sitting up, Pt c/o HA. Pt assisted to the W/C and escorted to ED by RR team.
Patient reports excruciating pain day after vaccination, could not sleep from the pain. Reports Pain, Swelling, Redness with red blotchy raised skin(resembling rash), Hot to touch
Patient received ProQuad 3/1/07 and it was given again at 6/11/07 visit. On 6/25/07 patient developed a fever, rash and otitis media. There was concern, the rash may have been due to the duplicate vaccines.
Taste aversion to onions and coffee. A burnt/metallic/rancid smell/taste. Very strong. It has been over a week now. I am a chef and my palate is very developed. This is very bad for my career.
Left arm with painful, local swelling involving entire upper arm began within 12 hours of immunization.
"Moderna COVID-19 Vaccine EUA" A week after the first shot,  an itchy red area appeared on the inside of that arm.  It went away in about a week.  Approximately two weeks after the second shot, a small, red sore spot appeared on my left shoulder close to the joint of the collar bone with the arm bone.  Redness began to appear, first forming a streak downward.  By the end of the week, the redness continued to spread and pain developed in my bones on that shoulder.  On May 19, I was referred to Urgent Care by my normal healthcare provider.  There I was prescribed prednisone.   The course of treatment was 3 pills per day for four days, 2 pills per day for  four days and 1 pill per day for three days.  I have not yet finished  those pills.  The pain in the bones has decreased but the redness continues to spread.  Where it was at first just a streak that developed, it started over my shoulder and now has crossed the middle of my chest.  I had been told that I could stop taking the prednisone if the pain went away.  Earlier this week, I thought it was gone, so I didn't take the pills that day.  However, the next morning, the pain was back and I resumed the prednisone.
6 days after the first shot I began to feel dizzy, lightheaded, shortness of breath, chest pain, and fatigued. This occurred on and off for a few weeks. In mid-August I began to realize that my heart was skipping a beat at times. Started feeling better mid-September.
38 y.o female c/o fatigue and diarrhea x 2 wks post-Tdap vaccine. No redness, induration or arm pain at injection site. Symptoms started the next day also w/symptoms of sniffles, cough and runny nose I suspect viral syndrome. pt thinks due to Tdap.
continuous urination every 2 hours day and night since 4/1/21.  Totally wiped out.
Patient c/o throat "tightening" s/p Covid Pfizer#1. No respiratory distress.  No hives or rash. Rx cetirizine 10 mg PO and diphenhydramine 25 mg PO with H2O, Observed x 30 min total. No worsening of symptoms. Discharged.
After getting the DTP vaccine earlier that day, baby suddenly developed high fever that would not respond to Tylenol. Called Dr., who said to put baby in lukewarm bath to try to break fever and bring to office next day. Underarm temp taken with oral thermometer was as high as it could go - 107 degrees F, I think. After 4 hours in cooling bath, and as sun was coming up, fever finally broke. During fever, baby also had episodes of high pitched screaming and persistent crying.
Developed Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Developed Covid-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2022, the patient experienced COVID-19 (Developed Covid-19). At the time of the report, COVID-19 (Developed Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, SARS-CoV-2 test: Positive.         Concomitant medications were not provided.  Patient had developed Covid-19 on an unspecified date and was suggested to take Paxlovid. The patient was not hospitalized.  Treatment information was reported as the patient was suggested to take Paxlovid.
The patient states that he started experiencing symptoms of a dry cough, sore throat, mild generalized headache, and diarrhea two days ago. His wife was admitted to this hospital after being diagnosed with COVID-19 recently. The patient did take a home test for COVID-19 which was reportedly negative. Patient states that he decided to come into the ER today because he felt a little more confused than usual. He does report associated chills, but denies any documented fevers. Denies any chest pain, shortness of breath, abdominal pain, nausea, or vomiting. No urinary complaints. No loss of taste or smell
Flu shot 10/3/2013, 1 week later mild URI with tender OD -> seen in office 10/17. Dx'd as conjunctivitis - felt viral, no meds. 10/22 - HA developed, (R) temple HA, OD - pain increased, increased erythema -> sent to eye doc 10/23.
I tested positive for Covid on 11/14/2022.  high fever, body aches, headache, congested
Pt recv vax on 12/11/98; on12/12/98 pt exp LA hot, tender, sore, red & swollen; tx=Tylenol
Patient noticed itchy rash in the evening. No difficulty breathing or reaction at the injection site. No pain at the injection site. Took Benadryl at bedtime and applied anti-itch cream to the rash.
Never had svt until after vaccine. Happened about 2 1/2 to 3 weeks post, scheduled for ep study and ablation
Information has been received from a physician concerning a 17 year old female who on 01-JUN-1994 was vaccinated with the first dose of MMR II (lot number not reported) and on 14-OCT-1994 was vaccinated with the second dose of MMR II (lot number not reported). On 25-NOV-2009 the patient experienced mumps. It was noted that the patient had left parotitis. She had swelling under "left." The patient was afebrile. On 23-DEC-2009 the patient diagnosed with mumps. On 24-DEC-2009, blood work was performed (results not reported). Follow-up information was received which reported that the 17 (also reported as 18) year old patient on 21-NOV-2009 developed mumps. On 23-NOV-2009, the patient was fever 101F and was diagnosed. On the same date, laboratory data revealed that IgM <1:10, IgG 4.16 and serum amylase 48. The patient had parotitis. At the time of the report, the patient's status was unknown. No further information is available.
Chills, body aches, dry cough, cough attacks that caused vomiting, temperature of 99.
left arm  large wheal development two weeks after injection. About the size of a hand. itching swelling and warm.  treated with Caladryl
Patient said her heart feels like its racing and minor chest pain & tightness not bad enough that she needed to see the doctor.
Site: Pain at Injection Site-Severe, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Abdominal Pain-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium, Systemic: Hypertension-Medium, Systemic: Tachycardia-Medium
Information has been received from a registered nurse concerning a 47 month old female with no medical history who on 04OCT2000 was vaccinated with a first dose of varicella virus vaccine live SC in the left thigh. There was no illness at the time of vaccination. On 30AUG2003 the patient developed a rash of about 20 scattered vesicles,but had no fever. On 30AUG2003 the doctor in the emergency room confirmed chickenpox, also reported as a breakthrough case of chickenpox. It was noted that she required no treatment for her rash. There was no relevant diagnostic tests or laboratory data performed. On 07SEP2003 the vesicles "crusted over" and the patient was considered as recovered. The patient's brother also developed chickenpox at the same time. It was noted that her rash was milder than her brother's. It was also noted that they seemed to "break out on about the same day." No further information is expected.
Heart Palpitations. Random  Sharp pain around left side of chest area and even left side of neck and left back side.  Strange feeling in chest area which makes me cough frequently.
About 12:15 the next afternoon, I got visual blurring, difficulty with mental clarity and focus, and then developed a severe headache. At about 3:00 I vomited 4 times while at work! The rest of the evening, I had a bad headache and mental fog.  The nest day my left eye and right lower lip were swollen. I don't know if this is related but 4 days later, my tongue was swollen.
Breakthrough Covid case with symptoms after 2 Moderna shots and a booster (which I got the same day as the positive test result) . Second vaccine was 3/8/21 and booster was 11/4/21.  Cough and chest tightness were most significant symptoms. Cough remains after more than one month.  High blood pressure appears to have resolved too.
Crying, sweats, loss of color in skin and lips, lethargic, confused. Febrile seizure.
Unable to lift arm for 2 days post injection starting night of injection. Swollen, tissue harder to the touch. Patient states warm to the touch. Patient states they have been more tired than usual. Patient states entire upper arm is sore to touch.
Bell?s palsy on the left side of my face. This started a few months after the vaccine so not sure if it?s a side effect, but figured I should report it anyways. So far the Bell?s palsy has lasted about a month.
ON 2/10/21, DEVELOPED BODY ACHES, CHILLS, CHEST TIGHTNESS, NAUSEA, HEADACHE, AND FEVER.
forgot to come back for the second dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 1st October 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: forgot to come back for the second dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 01-JUN-2023 The patient forgot to come back for the second dose of Shingrix but returned to the same pharmacy on 16th February 2023.  The patient was informed that he/she had to start over.  When he/she returned at the time of reporting for the second shot they informed him/her the insurance would not cover it because they only cover 2 shots of Shingrix. If he/she got it they would charge him/her.  After speaking to his/her insurance company, they informed him/her the disease control did not recommend getting another shot, so they would not cover it.  Additionally, she said that she could talk to his/her physician and had him administer it in his office so it would not go through his/her prescription coverage.  This was conflicting information. So reporter asked if he/she should get another shot of Shingrix or not. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Suffered for 2 months/Bedbound; This case was reported by a consumer via interactive digital media and described the occurrence of bedridden in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included disability.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced bedridden. On an unknown date, the outcome of the bedridden was recovered/resolved.   It was unknown if the reporter considered the bedridden to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 20-JUN-2022 Reporter's Comments: This case was reported by patient via interactive digital media. The patient had 1st vaccine few months prior to the reporting and suffered for 2 months. The patient was bedbound. The patient did not take 2nd shot under doctor's advice. The patient was disabled, and she believed that nature of her disability caused this. The patient husband had vaccine at same time, and he was fine. The patient stated that please check with your doctor before taking vaccine.
The evening after the vaccine was given, the patient became sick with a fever (101), body aches, headache, and nausea. For the next two days she felt awful, as if she had the flu. She also had a chicken egg sized knot on her arm with redness and itching. Most of the swelling went down 4 days later, but it still itches and she is uing Benadryl to help it. This is the first time this has happened to her with the flu shot.
Load of panic attacks; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Load of panic attacks) and PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02AL20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included Anxiety. Concomitant products included BUPROPION for COVID-19 vaccination, LORAZEPAM for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (Fever). On 14-Mar-2021, the patient experienced PANIC ATTACK (Load of panic attacks). At the time of the report, PANIC ATTACK (Load of panic attacks) and PYREXIA (Fever) outcome was unknown. Not Provided          No treatment medications were reported.
HIGH BLOOD PRESSURE 155/110; This spontaneous report received from a patient concerned a 61 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included borderline high blood pressure usually around 120/83-84.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 042A21A and expiry: UNKNOWN) dose was not reported, 1 total administered on 06-APR-2021 to left arm for prophylactic vaccination. Concomitant medications included 10mg enalapril as maintenance for borderline high blood pressure.  On 07-APR-2021, 24 hours after receiving the vaccine, the patient experienced high blood pressure 155/110 and the patient also had slight dizziness and severe headaches.  Laboratory data included: Blood pressure (NR: not provided) 155/110. For treatment, the patient took 20mg enalapril after measuring blood pressure which was not therapeutic, so the patient took nifedipine 10mg which was effective. The patient was feeling well and had no symptoms or complaints at the time of this report. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from high blood pressure 155/110, slight dizziness, and severe headaches on APR-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210420121-covid-19 vaccine ad26.cov2.s - High blood pressure 155/110. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: UNDERLYING DISEASE
Fever started on 8/12/2019, it went up to 104.4 the night of 8/13/2019.  The next morning, 8/14/2019, patient woke up with a mild rash on the back of her neck, chest-stomach area and back.  Rash is sparse in other areas.  Mild itchiness reported by patient.  No other symptoms reported.